Lisata Therapeutics, certepetide, LSTA1, pancreatic cancer, solid tumors, USPTO, method-of-use patent, oncology, cancer drug delivery, immunotherapy

LIBERTY CORNER, N.J. — October 8, 2026 Lisata Therapeutics, Inc. announced that the U.S. Patent and Trademark Office (USPTO)...